152 related articles for article (PubMed ID: 2368724)
21. Improving adverse drug reaction reporting in the community setting.
McCloskey BA
Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
[TBL] [Abstract][Full Text] [Related]
22. An ADR surveillance program: increasing quality, number of incidence reports.
Orsini MJ; Orsini PA; Thorn DB; Gallina JN
Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
[TBL] [Abstract][Full Text] [Related]
23. Review of Canadian pharmacist involvement in adverse drug reaction reporting.
Taras-Zasowski KM; Einarson TR
Can J Hosp Pharm; 1989 Jun; 42(3):105-8, 133. PubMed ID: 10318271
[TBL] [Abstract][Full Text] [Related]
24. Reporting adverse drug reactions on a geriatric ward: a pilot project.
Somers A; Petrovic M; Robays H; Bogaert M
Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
[TBL] [Abstract][Full Text] [Related]
25. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
Murphy BM; Frigo LC
Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
[TBL] [Abstract][Full Text] [Related]
26. A survey of adverse drug reaction reporting programs in select hospitals.
Case RL; Guzzetti PJ
Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
[TBL] [Abstract][Full Text] [Related]
27. Adverse drug reaction monitoring in Mississippi home health care agencies.
Szeinbach SL; Fincham JE; Garner DD; Brown TR
Home Health Care Serv Q; 1991; 12(1):47-55. PubMed ID: 10110885
[TBL] [Abstract][Full Text] [Related]
28. Incidence of adverse drug reactions in adult medical inpatients.
Bowman L; Carlstedt BC; Black CD
Can J Hosp Pharm; 1994 Oct; 47(5):209-16. PubMed ID: 10172139
[TBL] [Abstract][Full Text] [Related]
29. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
[TBL] [Abstract][Full Text] [Related]
30. Adverse drug reaction reporting: a working system.
Michelson PA; Shields K
Hosp Pharm; 1987 Jul; 22(7):682-4. PubMed ID: 10282685
[TBL] [Abstract][Full Text] [Related]
31. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
Ramesh M; Pandit J; Parthasarathi G
Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
[TBL] [Abstract][Full Text] [Related]
32. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
Saltiel E; Johnson E; Shane R
Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
[TBL] [Abstract][Full Text] [Related]
33. Use and reported adverse effects of new chemical entities.
Kennedy DL; Goetsch RA; Dreis MW
Am J Hosp Pharm; 1989 Mar; 46(3):558-65. PubMed ID: 2719041
[TBL] [Abstract][Full Text] [Related]
34. Pharmacist-managed monitoring of adverse reactions to contrast media.
Damiani DR; Swanson DP
Am J Hosp Pharm; 1994 Feb; 51(3):358-63. PubMed ID: 8160688
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of an indirect method of detecting adverse reactions to anticoagulants.
Swanson CN; Keys PW
Am J Hosp Pharm; 1987 Mar; 44(3):544-8. PubMed ID: 3565412
[TBL] [Abstract][Full Text] [Related]
36. Impact of the development of a multidisciplinary adverse drug reaction committee.
Etzel JV; Brocavich JM; Rousseau M
Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
[TBL] [Abstract][Full Text] [Related]
37. The role of hospital and community pharmacists in pharmacovigilance.
van Grootheest AC; de Jong-van den Berg LT
Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
[TBL] [Abstract][Full Text] [Related]
38. Adverse drug reactions: a review of relevant factors.
Ajayi FO; Sun H; Perry J
J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
[TBL] [Abstract][Full Text] [Related]
39. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
Tyler LS; Nickman NA
Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
[TBL] [Abstract][Full Text] [Related]
40. Nurses are increasingly involved in pharmacovigilance in Sweden.
Ulfvarson J; Mejyr S; Bergman U
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
